Marijuana Industry at Inflection Point: Trump's Policy Targets Banking and Business Loans Access

For years, cannabis operators have endured a peculiar paradox: running billion-dollar businesses yet unable to access the financial infrastructure that most industries take for granted. This fundamental constraint stems from decades-old federal classification that has locked marijuana companies out of traditional banking relationships and conventional business lending. That dynamic may finally be shifting.

In December, President Trump signed an executive order moving marijuana from Schedule I to Schedule III—a recategorization that doesn’t immediately legalize recreational use nationwide, but addresses the cash-flow crisis that has forced the $30 billion industry to operate like an underground economy. For executives weighing whether this moment differs from previous false starts, the details matter.

Why Marijuana Businesses Have Been Locked Out of Traditional Loans

The primary obstacle hindering marijuana business loans isn’t regulatory ideology—it’s basic finance. Banks typically require collateral before extending credit, but lenders have historically viewed cannabis company assets as proceeds from federal crimes. This legal limbo made institutional financing virtually impossible, regardless of a company’s profitability or management quality.

Smaller operators particularly suffer. A CEO at one multi-state firm told NPR that his company set aside $38 million during 2024 alone to cover anticipated IRS penalties and interest—money that could have funded expansion, hiring, or technology investment. When a company must reserve nearly 10% of its annual budget for potential tax liabilities rather than growth initiatives, the industry-wide capital constraints become apparent.

Reclassifying marijuana to Schedule III removes the federal crime classification that made banks legally nervous about serving the sector. While this alone won’t instantly transform lending practices—financial institutions still need to update compliance systems and navigate ongoing restrictions on interstate commerce—it eliminates the core legal conflict that kept mainstream lenders sidelined.

The Tax Crisis Strangling Cannabis Operations

Beyond access to loans, taxation represents the most immediate stranglehold on profitability. Section 280E of the U.S. Tax Code prohibits cannabis businesses from deducting ordinary operating expenses like rent, salaries, utilities, or inventory costs—a prohibition stemming from marijuana’s Schedule I classification.

The math becomes punishing. Standard industries operate at effective federal tax rates between 20-30%, but cannabis firms routinely face 60-90% rates on their cannabis-related income. According to industry research firm GreenWave Advisors, between 2019 and September 2025, the eight largest multi-state cannabis operators reported owing $2.6 billion in federal taxes but paid only $600 million of that amount. The unpaid balance reflects not deliberate tax evasion but sheer economic pressure—many companies literally lack cash to pay.

Moving marijuana to Schedule III would eliminate the legal justification for Section 280E’s discriminatory treatment. Suddenly, millions of dollars trapped in tax liability could flow back into operations. For investors evaluating whether this policy shift carries real momentum, this component is perhaps the most consequential.

Cash Dependency and Security Risks: The Dirty Secret of Dispensaries

The Schedule I classification created another problem that doesn’t immediately register with policymakers but profoundly affects daily operations: payment processing remains impossible. Since most payment processors and banks refuse to work with federally prohibited substances, dispensaries cannot accept credit or debit cards. Customers either withdraw cash from on-site ATMs or bring their own—both awkward and problematic solutions.

This cash-dependency transforms retail locations into robbery targets. Criminals know that dispensaries hold significant cash reserves that competitors in regulated retail don’t maintain. Theft against cannabis retailers occurs at rates far exceeding conventional pharmacies or grocery stores, draining additional resources toward security infrastructure and insurance.

Beyond robbery risk, the inability to maintain traditional bank accounts hampers a fundamental business operation: securing conventional business loans. Lenders cannot reliably monitor cash flows or establish accountability when transactions occur entirely outside the banking system. Reclassification wouldn’t instantly resolve this problem—banks still need updated compliance frameworks—but the underlying legal risk that deterred their participation would substantially diminish.

From Schedule I to III: What the Executive Order Actually Changes

Trump’s reclassification doesn’t represent legalization, nor does it resolve every challenge facing cannabis operators. Interstate commerce restrictions remain, state-level prohibition persists in some jurisdictions, and social stigma hasn’t evaporated. The order requires implementation by the Justice Department and faces potential legal challenges from opponents.

What it does accomplish is removing the single largest legal obstacle to financial system participation. Once Schedule III status takes effect, marijuana-related businesses transform from de facto criminal enterprises in the eyes of banking regulators to merely regulated commercial operations—like alcohol production or pharmaceutical manufacturing. That distinction opens doors.

For marijuana business loans specifically, Schedule III status creates the preconditions for lending institutions to develop appropriate compliance protocols and evaluate applications on financial merit rather than blanket prohibition. It doesn’t guarantee loan approval or eliminate other business requirements, but it returns to lenders the option to participate.

Will the Market Believe This Time? Skepticism Meets Opportunity

When Trump signed the order, cannabis stocks reacted counterintuitively—the AdvisorShares Pure US Cannabis ETF declined 27% that day and continued falling. Part of this reaction reflects normal market behavior: prices had surged in anticipation, and investors locked in gains once the order became official. Profit-taking always follows announcements.

But the decline also reflects something deeper: accumulated disappointment. The Biden administration initiated a similar reclassification process that ultimately stalled, derailed by bureaucratic friction and political opposition. Multiple previous attempts to reform cannabis taxation and banking rules have floundered in Congress. Investors who’ve lived through these cycles understandably display caution.

What distinguishes this moment is Trump’s demonstrated willingness to advance previously untouchable sectors. In July, his administration enacted the GENIUS Act, establishing the first comprehensive federal regulatory framework for cryptocurrency—a sector facing banking and taxation barriers remarkably similar to cannabis. His administration has similarly prioritized psychedelics research, with the FDA designating it a “top priority” and the Veterans Affairs conducting clinical trials on psilocybin therapeutics.

This pattern suggests the administration possesses both political will and operational capacity to execute on stated priorities.

Real Progress on the Ground: 400,000 Jobs and Counting

The scale of what reclassification could unlock deserves emphasis. Colorado surpassed $1 billion in marijuana sales in 2025, generating approximately $200 million in state tax revenue. The cannabis industry now supports over 400,000 direct jobs across nearly 15,000 licensed retail locations. These represent legitimate businesses serving legal customers, yet they remain constrained by regulations designed for illicit drug trafficking operations.

This disconnect between the economic reality and the regulatory framework becomes harder to justify as the industry matures. A sector generating $200 million in tax revenue for a single state, employing hundreds of thousands, and operating transparently within existing state frameworks no longer resembles an underground economy.

Whether this executive order marks genuine reform or merely another delayed promise remains uncertain. But for an administration that has repeatedly demonstrated resolve on previously dormant issues, underestimating its follow-through capacity would repeat previous analytical errors.